Medindia LOGIN REGISTER
Medindia
Advertisement

Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends

Thursday, December 3, 2009 General News
Advertisement


NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Contract Manufacturing - Global Market Trends
Advertisement

http://www.reportlinker.com/p0164248/Pharmaceutical-Contract-Manufacturing---Global-Market-Trends.html

Global pharma industry faces numerous challenges in the form of increasing competition in generic markets, rising cost of new product development, declining research and development (R&D) productivity, shrinking average patent life, and mounting governmental pressure to reduce drug prices. Given the backdrop of such a competitive landscape, the decisive factors for growth and sustainability are faster new drug development and cost containment with Pharmaceutical Contract Manufacturing emerging as a strategic option offering several advantages. Firstly, outsourcing provides pharma companies the opportunity to avail flexibility, quicker time to market, and lower scale-up costs. Thus, companies will be able to meet growing demand for new drugs and focus on their core competencies. Secondly, outsourcing enables companies to reduce excess capacity in their manufacturing networks and restructure supply chains. Finally, value-added outsourcing services meet the increased demand for specialized manufacturing capabilities in key technical niches (such as lyophilization) and increased demand for back-up sources of supply.
Advertisement

These and other market data and trends are presented in "Pharmaceutical Contract Manufacturing: Global Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

PHARMACEUTICAL CONTRACT MANUFACTURING BMR-1048

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. MARKET DYNAMICS 4

An Insight into the Rise of PCM 4

Industry Potential 4

3. SERVICE OVERVIEW 5

Introduction 5

Injectables (injections, vials, and IV solutions) 5

Solid Dosage Forms (SDFs) (Tablets and Capsules) 5

Liquid Dosage Forms (LDFs) (Syrups and Suspensions) 6

A Focus on Bio-Manufacturing 6

4. TRENDS AND ISSUES 7

Outsourcing Emerges as a Strategic Priority for Pharmaceutical

Companies 7

Asia Dominates Regional Growth, North America Retains Position

as Largest Market 8

Virtual Pharma vs. Blockbuster Model 8

Investment Risks in Pharmaceutical Contract 9

Quality Assurance Risk 9

Drug Development Risk 9

Acquisition Risk 9

Client Dependency Risk 9

5. CORPORATE DEVELOPMENTS 9

Jubilant Acquires Draxis for US$ 253 Million 9

JHP Acquires Assets of King Pharmaceuticals 10

NextPharma Acquires Bioserv Corporation 10

Dr. Reddy's to Acquire Dowpharma's Facilities 10

PharmAthene to Acquire Avecia's Biodefense Vaccine Operations 11

Bioserv Enters into an Outsourcing Agreement with BioLife

Solutions 12

Eden Biodesign and Stealthyx Therapeutics Ink an Agreement 12

NPIL Pharma to Expand HPS Sites in Scotland 12

Dishman Pharma Installs New API Facilities 13

Patheon Divests Niagara-Burlington Manufacturing Business to

Pharmetics 13

Jubilant Organosys Acquires Hollister-Stier Laboratories 13

Hikma Pharmaceuticals Acquires Thymoorgan GmbH Pharmazie 14

Meda Acquires Recip 14

Keata Pharma to Acquire Pfizer's Production Facility in Canada 15

STADA Acquires MAKIZ 15

Nextpharma to Expand its Cytostatics Production Facility 16

Haupt Pharma Establishes Production Facility in Malta 16

6. MAJOR PLAYERS 17

Althea Technologies (USA) 17

Catalent Pharma Solutions (USA) 17

Dishman Pharmaceuticals and Chemicals Ltd (India) 17

HAUPT Pharma AG (Germany) 18

Jubilant Organosys Ltd (India) 18

Kemwell Pvt. Ltd (India) 18

NextPharma (UK) 18

Nipro Corp (Japan) 18

Patheon, Inc. (Canada) 19

Penn Pharmaceutical Services Ltd (UK) 19

Royal DSM N.V. (Netherlands) 19

7. MARKET ANALYTICS 20

8. THE UNITED STATES 24

Trends 24

Pharma Companies Increasingly Outsource Manufacturing Activity 24

Injectables Segment Witnesses Upward Growth Trend 24

Competitive Landscape 24

9. CANADA 26

10. JAPAN 27

Impact of Contract Manufacturing on Japanese Pharmaceutical

Sector 27

11. EUROPE 28

Trend 28

Injectables Segment Offers Promising Potential 28

Competitive Scenario 28

12. ASIA-PACIFIC 30

Trends 30

Upbeat Market for Pharmaceutical Contract Manufacturing 30

Competitive Scenario 30

India 30

13. REST OF WORLD 32

EXHIBITS

Table 1: Global Markets for Pharmaceutical Contract

Manufacturing by Region for the Period 2007-2015 (Sales in US$

Million)

Table 2: Percentage Breakdown of Global Markets for

Pharmaceutical Contract Manufacturing by Region for the Years

2008 & 2012

Table 3: Global Markets for Pharmaceutical Contract

Manufacturing of Injectables by Region for the Period

2007-2015 (Sales in US$ Million)

Table 4: Percentage Breakdown of Global Markets for

Pharmaceutical Contract Manufacturing of Injectables by

Region for the Years 2008 & 2012

Table 5: Global Markets for Pharmaceutical Contract

Manufacturing of Solid Dosage Forms by Region for the Period

2007-2015 (Sales in US$ Million)

Table 6: Percentage Breakdown of Global Markets for

Pharmaceutical Contract Manufacturing of Solid Dosage Forms by

Region for the Years 2008 & 2012

Table 7: Global Markets for Pharmaceutical Contract

Manufacturing of Liquid Dosage Forms by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 8: Percentage Breakdown of Global Markets for

Pharmaceutical Contract Manufacturing of Liquid Dosage Forms

by Region for the Years 2008 & 2012

Table 9: Pharmaceutical Contract Manufacturing Market by

Product Segment in the US: 2007-2015 (Sales in US$ Million)

Table 10: Percentage Breakdown of Pharmaceutical Contract

Manufacturing Market by Product Segment in the US for the

Years 2008 & 2012

Table 11: Pharmaceutical Contract Manufacturing Market by

Product Segment in Canada: 2007-2015 (Sales in US$ Million)

Table 12: Percentage Breakdown of Pharmaceutical Contract

Manufacturing Market by Product Segment in Canada for the

Years 2008 & 2012

Table 13: Pharmaceutical Contract Manufacturing Market by

Product Segment in Japan: 2007-2015 (Sales in US$ Million)

Table 14: Percentage Breakdown of Pharmaceutical Contract

Manufacturing Market by Product Segment in Japan for the Years

2008 & 2012

Table 15: Pharmaceutical Contract Manufacturing Market by

Product Segment in Europe: 2007-2015 (Sales in US$ Million)

Table 16: Percentage Breakdown of Pharmaceutical Contract

Manufacturing Market by Product Segment in Europe for the

Years 2008 & 2012

Table 17: Pharmaceutical Contract Manufacturing Market by

Product Segment in Asia-Pacific: 2007-2015 (Sales in US$

Million)

Table 18: Percentage Breakdown of Pharmaceutical Contract

Manufacturing Market by Product Segment in Asia-Pacific for

the Years 2008 & 2012

Table 19: Pharmaceutical Contract Manufacturing Market by

Product Segment in Rest of World: 2007-2015 (Sales in US$

Million)

Table 20: Percentage Breakdown of Pharmaceutical Contract

Manufacturing Market by Product Segment in Rest of World for

the Years 2008 & 2012

COMPANIES PROFILED

To order this report:

Medical Equipment and Supply Industry: Pharmaceutical Contract Manufacturing - Global Market Trends

More Market Research Report

Nicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close